Related Experiment Video
Updated: May 15, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Milk Exosomes From Gestational Diabetes Mellitus Parturients Demonstrate Weaker Ability to Promote Intestinal
Jiaqi Mo1, Yudi Ding1, Junyi Yang1,2
1Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, National Medical Products Administration (NMPA) Key Laboratory for Safety Evaluation of Cosmetics, School of Public Health, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Human milk exosomes from mothers with gestational diabetes (GDM-EXO) show a weaker ability to promote infant intestinal development compared to healthy exosomes (HEA-EXO). This difference is linked to altered gut microbiota and miRNA profiles in GDM-EXO.
Area of Science:
- Perinatology
- Gastroenterology
- Molecular Biology
Background:
- Human milk exosomes (HMEs) play a crucial role in infant development.
- Gestational diabetes mellitus (GDM) may alter the composition and function of HMEs.
- Understanding GDM-HME effects on infant gut health is vital for early intervention.
Purpose of the Study:
- To investigate differences between GDM-HMEs (GDM-EXO) and healthy HMEs (HEA-EXO) in promoting offspring intestinal development.
- To analyze differential microRNAs (miRNAs) and their correlation with gut microbiota (GM) in infants exposed to GDM-EXO vs. HEA-EXO.
- To assess the impact of GDM-EXO and HEA-EXO on intestinal morphology and gut barrier function in a mouse model.
Main Methods:
- Quantitative PCR (qPCR) to verify differential miRNAs in GDM-EXO and HEA-EXO.
- 16S rDNA amplicon sequencing to analyze infant gut microbiota composition.
- Gavage of C57BL/6J mice with GDM-EXO or HEA-EXO, followed by histological staining, Western blotting for gut barrier proteins (ZO-1, Occludin), and GM analysis.
Main Results:
- GDM-EXO exhibited altered miRNA profiles (upregulated: hsa-miR-19b-3p, hsa-miR-148a-3p, hsa-miR-320a-3p; downregulated: hsa-miR-429) compared to HEA-EXO.
- Infants exposed to GDM-EXO showed altered gut microbiota (increased Coriobacteriaceae, Clostridiaceae, Erysipelotrichaceae, Erysipelatoclostridiaceae; decreased Lactobacillaceae).
- GDM-EXO demonstrated a weaker capacity to enhance intestinal morphology (villus length, villus length-to-crypt depth ratio, goblet cell number) and gut barrier integrity (ZO-1, Occludin) in mice compared to HEA-EXO.
Conclusions:
- Human milk exosomes from GDM parturients (GDM-EXO) have a diminished ability to promote intestinal development in offspring compared to those from healthy parturients (HEA-EXO).
- Differential miRNAs and gut microbiota alterations are associated with GDM-EXO's impact on infant gut health.
- These findings highlight the potential negative effects of GDM on infant gut development mediated by exosomal components in breast milk.
More Related Videos
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

